The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2-(4-(Benzylamino)-6-(methylamino)-1,3,5-triazin-2-yl)phenyl)methanol ID: ALA4465217
PubChem CID: 155531015
Max Phase: Preclinical
Molecular Formula: C18H19N5O
Molecular Weight: 321.38
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CNc1nc(NCc2ccccc2)nc(-c2ccccc2CO)n1
Standard InChI: InChI=1S/C18H19N5O/c1-19-17-21-16(15-10-6-5-9-14(15)12-24)22-18(23-17)20-11-13-7-3-2-4-8-13/h2-10,24H,11-12H2,1H3,(H2,19,20,21,22,23)
Standard InChI Key: WXUBVAAOBZKYME-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
14.4604 -4.9568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4592 -5.7763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1673 -6.1853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8770 -5.7758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8741 -4.9532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1655 -4.5479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5773 -4.5432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2868 -4.9508 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9925 -4.5403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9898 -3.7222 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2756 -3.3164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5729 -3.7294 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.7015 -4.9465 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.4079 -4.5356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1169 -4.9419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1160 -5.7586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8243 -6.1648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5316 -5.7538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5263 -4.9324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8175 -4.5299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2697 -2.4993 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.1631 -3.7307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4541 -3.3242 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.9744 -2.0855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
5 7 1 0
9 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
11 21 1 0
6 22 1 0
22 23 1 0
21 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 321.38Molecular Weight (Monoisotopic): 321.1590AlogP: 2.68#Rotatable Bonds: 6Polar Surface Area: 82.96Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.32CX LogP: 3.48CX LogD: 3.45Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.65Np Likeness Score: -0.64
References 1. Yu X, Huang XP, Kenakin TP, Slocum ST, Chen X, Martini ML, Liu J, Jin J.. (2019) Design, Synthesis, and Characterization of Ogerin-Based Positive Allosteric Modulators for G Protein-Coupled Receptor 68 (GPR68)., 62 (16): [PMID:31298539 ] [10.1021/acs.jmedchem.9b00869 ]